Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (1101)	12/18/1997 11:53:00 PM
From: Bruce Rosen	Read Replies (2) \| Respond to of 7041

<<Oral mucosa and small intestine are one and the same? That is quite a stretch. Topologically- yes. Histologically- no. Is their special formulation of phentolamine patented then? >> In my post which you responded to with the above reference, I did say that the above interpretation, if it stood alone, would concern me. I also said that they were awaiting the patent for their special formulation and were advised by counsel that they felt confident they would get the patent soon. As you might be aware, these matters do take time. If Joe Podolski was telling an outright lie when he publically stated this, then he is a wonderful actor, with no concerns about going to jail. I feel that he sincerely believed that he was relating truthful information. Further, as I stated, Schering-Plough did a thorough review of the patent situation and eagerly signed this deal. There were other major drug companies that also reviewed this and were willing to sign a deal. Do you think that if they did announce approval of this second patent for their formulation, it would have a major effect on the price of the stock?